Huntington's disease (HD) is an untreatable inherited adult onset neurodegenerative disease caused by an abnormal expansion in the polyglutamine (polyQ) tract in the Huntington (Htt) protein. The polyQ expansion makes mutant Htt (mHtt) prone to aggregate, but the relationship between aggregation and neurodegeneration has been difficult to understand. In the previous funding period, we invented a new imaging platform to study a neuron model of HD and discovered that the aggregation of mHtt into visible deposits called inclusion bodies (IBs) appears to be a coping response. Recently, we developed new methods to study neuronal protein homeostasis in the context of mHtt in live neurons. Surprisingly, we showed that neurons recognize and target mHtt for accelerated degradation in vitro and in vivo. Remarkably, we found that the protein homeostasis and clearance capacity of different types of neurons varies and significantly predicts their susceptibility to mHtt. We discovered that a major protein clearance pathway called autophagy is differentially regulated in neurons. We found small molecules that stimulate neuronal autophagy and showed that they lower mHtt levels and protect them from neurodegeneration. These findings have led to the overarching hypothesis that motivates this proposal: the demand made by aggregation-prone mHtt on the protein homeostasis network of susceptible neurons exceeds their capacity leading to neurodegeneration. In the first Aim, we will investigate how neurons recognize and respond to misfolded protein. The highly conserved heat shock response mediates responses to misfolded proteins in most cells, but it seems different and ineffective in neurons.
In Aim 2, we will test two major hypotheses about how protein dyshomeostasis leads to neurodegeneration-that inadequate capacity created by the demands of mHtt (1) leads to cell-wide protein misfolding and deleterious loss-of-function of metastable proteins or (2) a competition for flux through critical clearance pathways such as mitochondria and accumulation of substrates, such as dysfunctional mitochondria.
In Aim 3, we propose to adapt our powerful in vitro single cell longitudinal methods to study neuronal protein homeostasis and Htt metabolism in vivo. The results could help validate the protein dyshomeostasis model of HD and lead to new therapies.

Public Health Relevance

This is a competing renewal of a highly productive research program on Huntington's disease, which led to the development of a novel imaging platform for cell biology. With it, we made the surprising discovery that neurons with mutant huntingtin (mHtt) that form inclusion bodies (IB) live longer than those that don't form an IB. We also discovered that neurons regulate protein homeostasis differently than non-neuronal cells in key ways that could be relevant to neurodegenerative disease. In this proposal, we will dig deeper to understand the homeostatic mechanisms neurons have for responding to protein misfolding and test two key ideas for how protein dyshomeostasis causes neurodegeneration. During the previous funding period, we discovered compounds that stimulate an important component of the protein homeostasis system, a clearance pathway called autophagy. We showed that they protect neurons from mHtt-induced degeneration in vitro and in this proposal we will develop ways to adapt our powerful in vitro single cell methods for studying protein homeostasis in vivo.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Sutherland, Margaret L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
J. David Gladstone Institutes
San Francisco
United States
Zip Code
Kratter, Ian H; Zahed, Hengameh; Lau, Alice et al. (2016) Serine 421 regulates mutant huntingtin toxicity and clearance in mice. J Clin Invest 126:3585-97
Shaby, Benjamin A; Skibinski, Gaia; Ando, Michael et al. (2016) A three-groups model for high-throughput survival screens. Biometrics 72:936-44
Haston, Kelly M; Finkbeiner, Steven (2016) Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. Annu Rev Pharmacol Toxicol 56:489-510
Lee, Jong-Min; Kim, Kyung-Hee; Shin, Aram et al. (2015) Sequence-Level Analysis of the Major European Huntington Disease Haplotype. Am J Hum Genet 97:435-44
Barmada, Sami J; Ju, Shulin; Arjun, Arpana et al. (2015) Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc Natl Acad Sci U S A 112:7821-6
Finkbeiner, Steven; Frumkin, Michael; Kassner, Paul D (2015) Cell-based screening: extracting meaning from complex data. Neuron 86:160-74
Moruno Manchon, Jose Felix; Uzor, Ndidi-Ese; Dabaghian, Yuri et al. (2015) Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy. Sci Rep 5:15213
Qiu, Haiyan; Lee, Sebum; Shang, Yulei et al. (2014) ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 124:981-99
Barmada, Sami J; Serio, Andrea; Arjun, Arpana et al. (2014) Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol 10:677-85
Tóth, Gergely; Gardai, Shyra J; Zago, Wagner et al. (2014) Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. PLoS One 9:e87133

Showing the most recent 10 out of 57 publications